VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor

The potential role of the very low density lipoprotein (VLDL) receptor in mediating VLDL-induced plasminogen activator inhibitor-1 (PAI-1) expression was studied in vitro. Cultured endothelial cells incubated with VLDL showed an increased secretion of PAI-1. This response to VLDL could be completely...

Full description

Bibliographic Details
Main Authors: Lennart Nilsson, Mats Gåfvels, Leena Musakka, Katharina Ensler, Dudley K. Strickland, Bo Angelin, Anders Hamsten, Per Eriksson
Format: Article
Language:English
Published: Elsevier 1999-05-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S002222752032126X
id doaj-7f34a73bfa334f6f9e9759ac046c73d9
record_format Article
spelling doaj-7f34a73bfa334f6f9e9759ac046c73d92021-04-27T04:42:11ZengElsevierJournal of Lipid Research0022-22751999-05-01405913919VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptorLennart Nilsson0Mats Gåfvels1Leena Musakka2Katharina Ensler3Dudley K. Strickland4Bo Angelin5Anders Hamsten6Per Eriksson7To whom correspondence should be addressed.; Atherosclerosis Research Unit, King Gustaf V Research Institute, Department of Medicine, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, SwedenCenter for Metabolism and Endocrinology, Department of Medicine, and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, SwedenAtherosclerosis Research Unit, King Gustaf V Research Institute, Department of Medicine, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, SwedenCenter for Metabolism and Endocrinology, Department of Medicine, and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, SwedenDepartment of Vascular Biology, Holland Laboratory, American Red Cross, Rockville, MD 20855Center for Metabolism and Endocrinology, Department of Medicine, and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, SwedenAtherosclerosis Research Unit, King Gustaf V Research Institute, Department of Medicine, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, SwedenAtherosclerosis Research Unit, King Gustaf V Research Institute, Department of Medicine, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, SwedenThe potential role of the very low density lipoprotein (VLDL) receptor in mediating VLDL-induced plasminogen activator inhibitor-1 (PAI-1) expression was studied in vitro. Cultured endothelial cells incubated with VLDL showed an increased secretion of PAI-1. This response to VLDL could be completely prevented by the receptor-associated protein (RAP) and partially blocked by rabbit polyclonal anti-VLDL receptor IgG. Furthermore, Chinese hamster ovary (CHO) control cells and cells overexpressing the VLDL receptor were transiently transfected with a PAI-1 promoter–reporter construct and incubated with VLDL. The PAI-1 promoter activity in response to VLDL was significantly higher in the VLDL receptor overexpressing cells compared to the control cells. Addition of RAP completely blocked the VLDL-activated PAI-1 transcription. Electromobility shift assay was performed to investigate whether the enhanced PAI-1 promoter activity seen in the VLDL receptor overexpressing cells in response to VLDL involved induction of the previously described VLDL-inducible factor(s) binding to the –675 to –653 region of the PAI-1 promoter. We found that the binding of the VLDL-inducible factor in VLDL receptor overexpressing cells was markedly enhanced by addition of VLDL as compared to control cells where no increased binding could be seen in response to VLDL. In summary, these results indicate that the VLDL receptor is a strong candidate for mediating VLDL effects on PAI-1 synthesis and secretion in cells expressing this receptor.—Nilsson, L., M. Gåfvels, L. Musakka, K. Ensler, D. K. Strickland, B. Angelin, A. Hamsten, and P. Eriksson. VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor. J. Lipid Res. 1999. 40: 913–919.http://www.sciencedirect.com/science/article/pii/S002222752032126XatherosclerosistransfectionVLDL response element
collection DOAJ
language English
format Article
sources DOAJ
author Lennart Nilsson
Mats Gåfvels
Leena Musakka
Katharina Ensler
Dudley K. Strickland
Bo Angelin
Anders Hamsten
Per Eriksson
spellingShingle Lennart Nilsson
Mats Gåfvels
Leena Musakka
Katharina Ensler
Dudley K. Strickland
Bo Angelin
Anders Hamsten
Per Eriksson
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor
Journal of Lipid Research
atherosclerosis
transfection
VLDL response element
author_facet Lennart Nilsson
Mats Gåfvels
Leena Musakka
Katharina Ensler
Dudley K. Strickland
Bo Angelin
Anders Hamsten
Per Eriksson
author_sort Lennart Nilsson
title VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor
title_short VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor
title_full VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor
title_fullStr VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor
title_full_unstemmed VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor
title_sort vldl activation of plasminogen activator inhibitor-1 (pai-1) expression: involvement of the vldl receptor
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 1999-05-01
description The potential role of the very low density lipoprotein (VLDL) receptor in mediating VLDL-induced plasminogen activator inhibitor-1 (PAI-1) expression was studied in vitro. Cultured endothelial cells incubated with VLDL showed an increased secretion of PAI-1. This response to VLDL could be completely prevented by the receptor-associated protein (RAP) and partially blocked by rabbit polyclonal anti-VLDL receptor IgG. Furthermore, Chinese hamster ovary (CHO) control cells and cells overexpressing the VLDL receptor were transiently transfected with a PAI-1 promoter–reporter construct and incubated with VLDL. The PAI-1 promoter activity in response to VLDL was significantly higher in the VLDL receptor overexpressing cells compared to the control cells. Addition of RAP completely blocked the VLDL-activated PAI-1 transcription. Electromobility shift assay was performed to investigate whether the enhanced PAI-1 promoter activity seen in the VLDL receptor overexpressing cells in response to VLDL involved induction of the previously described VLDL-inducible factor(s) binding to the –675 to –653 region of the PAI-1 promoter. We found that the binding of the VLDL-inducible factor in VLDL receptor overexpressing cells was markedly enhanced by addition of VLDL as compared to control cells where no increased binding could be seen in response to VLDL. In summary, these results indicate that the VLDL receptor is a strong candidate for mediating VLDL effects on PAI-1 synthesis and secretion in cells expressing this receptor.—Nilsson, L., M. Gåfvels, L. Musakka, K. Ensler, D. K. Strickland, B. Angelin, A. Hamsten, and P. Eriksson. VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor. J. Lipid Res. 1999. 40: 913–919.
topic atherosclerosis
transfection
VLDL response element
url http://www.sciencedirect.com/science/article/pii/S002222752032126X
work_keys_str_mv AT lennartnilsson vldlactivationofplasminogenactivatorinhibitor1pai1expressioninvolvementofthevldlreceptor
AT matsgafvels vldlactivationofplasminogenactivatorinhibitor1pai1expressioninvolvementofthevldlreceptor
AT leenamusakka vldlactivationofplasminogenactivatorinhibitor1pai1expressioninvolvementofthevldlreceptor
AT katharinaensler vldlactivationofplasminogenactivatorinhibitor1pai1expressioninvolvementofthevldlreceptor
AT dudleykstrickland vldlactivationofplasminogenactivatorinhibitor1pai1expressioninvolvementofthevldlreceptor
AT boangelin vldlactivationofplasminogenactivatorinhibitor1pai1expressioninvolvementofthevldlreceptor
AT andershamsten vldlactivationofplasminogenactivatorinhibitor1pai1expressioninvolvementofthevldlreceptor
AT pereriksson vldlactivationofplasminogenactivatorinhibitor1pai1expressioninvolvementofthevldlreceptor
_version_ 1721506803666124800